10/31/2020
Welcome to Tiger King: Joe Exotic, Carol Baskin and the tigers!
Happy Halloween from IntegReview IRB
IntegReview is a fully accredited IRB responsible for providing protection to human research subjects in the pharmaceutical industry since 1999.
Quality and integrity are essential to the services IntegReview IRB provides. Human research is a field that relies on accuracy, honesty, individualized attention to details and the ability to respond quickly and effectively in a rapidly changing professional landscape. IRB staff and IRB members at IntegReview work in a fast-paced, highly responsive, open and adaptive culture that is reflected in
10/31/2020
Welcome to Tiger King: Joe Exotic, Carol Baskin and the tigers!
Happy Halloween from IntegReview IRB
10/29/2020
10/27/2020
10/22/2020
FDA Approves First Treatment for COVID-19 FDA approved Veklury (remdesivir) for adults and pediatric patients 12 years of age and older for the treatment of COVID-19 requiring hospitalization
10/21/2020
The FDA’s Vaccines and Related Biological Products Advisory Committee This week, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) is meeting to discuss vaccines to prevent COVID-19.
10/20/2020
Thank a Pharmacy Tech today!
10/16/2020
A year ago, the cystic fibrosis community celebrated the approval of Trikafta, a highly effective CFTR modulator for individuals who have at least one copy of the F508del mutation. Join us on Facebook Live Thursday, October 22 at 1 p.m. ET for plenary two of NACFC led by Jennifer Taylor-Cousar, MD, MSc, to learn about the amazing progress in our understanding of the benefits of highly effective CFTR modulators.
10/15/2020
NSAIDs may cause rare kidney problems in unborn babies NSAIDs may cause rare kidney problems in unborn babies
| Monday | 8am - 5pm |
| Tuesday | 8am - 5pm |
| Wednesday | 8am - 5pm |
| Thursday | 8am - 5pm |
| Friday | 8am - 5pm |